References and Articles

Recent Articles

  • Zhu, Z., Chung, Y.-M., Alyamani, M., Dai, Y., McCarty, K.D., Roberts, E., Sinha, S., Li, J., Li, X., Gad, E.M., Zhou, C., Shi, J., Burgess, R.A., Hargrove, T.Y., Lepesheva, G.I., Guengerich, F.P., Auchus, R.J., and Sharifi, N. (2025) Nature Commun.16, 10611.“A Bypass Gateway from Cholesterol to Sex Steroid Biosynthesis.”
  • Elizondo, A.I., McCarty, K.D., Guengerich, F.P., Arman, HJ.D., and Yoshimoto, F.K. (2025) Org. Biomolec. Chem. 23 (42) 9457-9724. “A Synthesis of 1b-Hydroxytestosterone, a Metabolite of Xenobiotic Human Cytochrome P450 Enzymes, Beginning with a Borylation of Boldione.” (selected for cover art)
  • McCarty, K.D., Tateishi, Y., and Guengerich, F.P. (2025) J. Biol. Chem. 301, 110378. “Cytochrome P450BM-3 and P450 11A1 Retain Compound I (FeO3+) Chemistry with Electrophilic Substrates Poised for Compound 0 (Fe3+O2¯) Reactions.”
  • McCarty, K.D., and Guengerich, F.P. (2025) J. Am. Soc. Mass Spectrom. 36, 1702-1717.  “Mass Spectral Analysis of Sterols and Other Steroids in Different Ionization Modes: Sensitivity and Oxidation Artifacts.”
  • Hong, J.-K., Yeom, M., Hwang, H.-Y., Mun, E., Woo, J.-H., Kim, Y., Shin, J.-H. Lee, Y., Kim, D., Guengerich. F.P., and Choi, J.-Y. (2025) Chem.-Biol. Interact.416, 111551. “Four Germline POLH Variants, Including Two Found in Skin Tumors, Impair DNA Polymerase h Function and Cellular Tolerance to UV Radiation and Cisplatin.”
  • McCarty, K.D., and Guengerich, F.P. (2025) J. Biol. Chem. 301, 108168. “Liver Fatty Acid Binding Protein FABP1 Transfers Substrates to Cytochrome P450 4A11 for Catalysis.”
  • Koinuma, K., Noto, K., Morita, T., Uekusa, Y., Kikuchi, H., Shimoji,  M., Seki, H., Yamazaki, H., Guengerich, F. P., Nakamura, K., Yamamoto, K., Imaoka, A., Akiyoshi, T., and Ohtani, H. (2025) J. Pharmaceut. Sci. 114, 849-856. “Kinetics of the Inhibition of CYP3A4 and CYP2C19 Activity by Jabara Juice and Identification of the Responsible Inhibitory Components.”
  • Tomar, R., Ghodke, P.P., Patra, A., Smyth, E., Ponatarelli, A., Copp, W.  Guengerich, F.P., Chaput, J.J., Wilds, C.J., Stone, M.P., and Egli, M. (2024) Biochemistry 63, 2425-2439. “DNA Replication Across a-L-(3′-2′)-Threofuranosyl Nucleotides Mediated by Human DNA Polymerase eta.”
  • Tateishi, Y., McCarty, K.D., Martin, M.V., Yoshimoto, F.K., and Guengerich, F.P. (2024) Angew. Chem., Int. Ed. 63, e202406542. “Roles of Ferric Peroxide Anion Intermediates (Fe3+O2¯) in Cytochrome P450 19A1 Steroid Aromatization and a Cytochrome P450 2B4 Secosteroid Model.”
  • Hargrove, T.Y., Lamb, D.C., Wawrazk, Z., Hull, M.T., Kelloy, S.L., La Scola, B., Guengerich, F.P., and Lepesheva, G.I. (2024) J. Med. Chem. 67, 7443-7457. “Identification of Potent and Selective Inhibitors of Acanthamoeba: Structural Insights into Sterol 14a-Demethylase as a Key Drug Target.”
  • Uehara, S., Murayama, N., Higuchi, Y., Shimizu, M., Suemizu, H. Guengerich, F.P., and Yamazaki, H. (2024) Chem. Res. Toxicol. 37, 671-674. “In Vivo and
    In Vitro Induction of Cytochrome P450 3A4 by Thalidomide in Humanized-Liver Mice and Experimental Human Hepatocyte HepaSH Cells.”
  • Tateishi, Y., McCarty, K.D., Martin, M.V., and Guengerich, F.P. (2024) ACS Catalysis. 14, 2388-2394. “Oxygen-18 Labeling Defines a Ferric Peroxide (Compound 0) Mechanism in the Oxidative Deformylation of Aldehydes by Cytochrome P450 2B4.”
  • Tateishi, Y., Webb, S.N., Li, B., Liu, L., Lindsey Rose, K., Leser, M., Patel, P., and Guengerich, F.P. (2024) J. Biol. Chem. 300, 105688. “Proteomics, Modeling, and Fluorescence Assays Delineate Cytochrome b5 Residues Involved in Binding and Stimulation of Cytochrome P450 17A1 Lyase.”
  • McCarty, K.D., Tateishi, Y., Hargrove, T.Y., Lepesheva, G.I., and Guengerich, F.P. (2024) Angew. Chem., Int. Ed. 320231771 “Oxygen-18 Labeling Reveals a Mixed Fe-O Mechanism in Cytochrome P450 51A1 Sterol 14a-Demethylation.”

 

Review Articles

  • Guengerich, F. P. (2026, in press) in Recent Advances in Biotransformation of Drugs and Drug Candidates (Isin, E.M., and Walles, M., Eds.) Wiley, New York. “Historical Perspective on Drug Metabolism.”
  • Norman, K.G., Kaufman, L.E., Greim, P., Loretz, L., Kowcz, A., Cohen, S.M., Scialli, A.R., Boobis, A.R., Jacobson-Kram, D., Schoeny, R., Rosol, T.J., Williams, G.M., Kaminski, N.E., Guengerich, F.P., and Nash, J.F. (2025) Crit. Rev. Toxicol. 55 (7), 716-734. “Comprehensive Review of Ensulizole Toxicology Data and Human Exposure Assessment for Personal Care Products.”
  • Norman, K.G., Kaufman, L.E., D’Ruiz, C., Loretz, L., Kowcz, A., Cohen, S.M., Scialli, A.R., Boobis, A.R., Jacobson-Kram, D., Schoeny, R., Rosol, T.J., Williams, G.M., Kaminski, N.E., Guengerich, F.P., and Nash, J.F. (2025) Crit. Rev. Toxicol. 55 (6), 662-692. doi: 10:1080/10408444.2025.2535394. “Comprehensive Review of Avobenzone  Toxicology Data and Human Exposure Assessment for Personal Care Products.”
  • Cohen, S.M., Rietjens, I.M.C.M., Levy, L., Berry, C., Boffetta, P., Boobis, A.R., Calabrese, E.J., Clewell, H., Cope, R., Cox, T., Dellarco, V., Dietrich, D., Dourson, M., Eaton, D.L., Fukushima, S., Gooderham, N.J., Goodman, J.I., Gori, G., Greim, H., Guengerich, F.P., Hagen, T., Hengstler, J.G., Jacobson-Kram, D., Klaassen, C., Klaunig, J.E., Lang, S., McClellan, R. O., Nebert, D..W., Paustenbach, D., Ramos, K., Rosol, T.J., and Wallace, K.B. (2025) Toxicol. Sci. 206, 1-3. “Chemical Risks and Children’s Health: Building on Progress Based on Science, Not Panic.”
  • Cohen, S.M., Boobis, A.R., Jacobson-Kram, D., Schoeny, R., Rosol, T.J., Williams, G.M., Kaminski, N.E., Eichenbaum, G.M., Guengerich, F.P., and Nash, J.F. (2025) Crit. Rev. Toxicol. 55, 248-284. “Mode of Action Supports a Lack of Carcinogenic Potential of Six Organic UV Filters.” DOI:10.1080/10408444.2025.2462642.
  • Guengerich, F.P. (2025, revised) Drug Metab. Rev. “Simplified Approaches to Kinetic Isotope Effects in Cytochrome P450-Catalyzed Reactions.”
  • Guengerich, F.P. (2024) J. Biol. Chem. 300, 105625. “Reflection: Ninety-eight Semesters of Cytochrome P450 Enzymes and Related Topics—What Have I Taught and Learned?”
  • Guengerich, F.P. (2024) Pharmacol. Rev. 76, 1104-1132. “Roles of Human Cytochrome P450 Enzymes in Drug Metabolism.”
  • Rendic, S.P., and Guengerich, F.P. (2024) Arch. Toxicol. 98, 1581-1628. “Bioactivation of Drugs to Potentially Toxic Products Catalyzed by Human Drug-Metabolizing Enzymes.”
  • Guengerich, F.P., Tateishi, Y., McCarty, K.D., and Yoshimoto, F.K. (2024) Int. J. Mol. Sci.25, 9020. “Recent Updates on Mechanisms of Cytochrome P450 Catalysis of Complex Steroid Oxidations.”
  • Guengerich, F.P. (2024) Drug Metab. Dispos. 52, 493-497. “Cytochrome P450 Enzymes as Drug Targets in Human Disease.”

Back Home   

Links

January 2026
S M T W T F S
 123
45678910
11121314151617
18192021222324
25262728293031